Emerging Coproduction of AmpC Beta-lactamase in Extended-spectrum Beta-lactamase-producing Escherichia coli Clinical Isolates in Indonesia
Biomolecular and Health Science Journal · 2024-01 · 7 (1) · 36-41
DOI: 10.4103/bhsj.bhsj_5_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecular and Health Science Journal, online erschienen am 20.06.2024. Verfasst von Mohammad Agung Marzah und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
A BSTRACT Introduction: Extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase (AmpC-BL) in Enterobacteriaceae are a global threat. Coproduction of AmpC-BL and ESBL reduces therapeutic options, with more resistance against cephamycin and beta-lactamase inhibitor combinations. This study determines the proportion, incidence, and distribution of AmpC-BL-resistant genes in clinically isolated ESBL-producing Escherichia coli , completing its scarce data in Indonesia.
Methods
The samples in this study were ESBL-producing E. coli from blood and urine specimens, confirmed by BD Phoenix semiautomatic examination combined with cefoxitin disk screening method. Confirmation tests of AmpC-BL used the AmpC-disk method and the polymerase chain reaction method.
Results
Thirteen (27.8%) of 108 E. coli isolates were nonsusceptible to cefoxitin, and 3 (11.5%) isolates were confirmed to produce AmpC-BL and contained AmpC-BL CITM gene. Of the 3 AmpC-BL and ESBL coproduction isolates, one isolate was a copresentation of ESBL and AmpC-BL genes, namely blaTEM and CITM. Fisher’s exact test showed that the coproduction of AmpC-BL in ESBL-producing isolates was associated with reduced susceptibility to cefoxitin ( P = 0.020) and amoxicillin-clavulanate ( P = 0.048) compared to isolates producing ESBL alone. The effect of ESBL and AmpC-BL coproduction on reducing susceptibility to carbapenems needs further investigation.
Conclusions
AmpC coproduction was found in 3 (2.8%) of 108 ESBL-producing E. coli isolates, and one isolate copresented AmpC-BL and ESBL coding genes blaTEM and CITM. These three isolates were associated with widened antibiotic resistance to cefoxitin and amoxicillin--clavulanate compared to isolates producing ESBL alone.
Zitieren
APA
Marzah, M. A., Sarassari, R., Safari, D., Maladan, Y., Setyarini, W., Sulistya, H. A., Endraswari, P. D., Shirakawa, T., Hirai, I., Kuntaman, K., & Koendhori, E. B. (2024). Emerging Coproduction of AmpC Beta-lactamase in Extended-spectrum Beta-lactamase-producing Escherichia coli Clinical Isolates in Indonesia. Biomolecular and Health Science Journal, 7(1), 36-41. https://doi.org/10.4103/bhsj.bhsj_5_24
Vancouver
Marzah MA, Sarassari R, Safari D, Maladan Y, Setyarini W, Sulistya HA, et al. Emerging Coproduction of AmpC Beta-lactamase in Extended-spectrum Beta-lactamase-producing Escherichia coli Clinical Isolates in Indonesia. Biomolecular and Health Science Journal. 2024;7(1):36-41. doi:10.4103/bhsj.bhsj_5_24
BibTeX
@article{Marzah2024,
author = {Marzah, Mohammad Agung and Sarassari, Rosantia and Safari, Dodi and Maladan, Yustinus and Setyarini, Wahyu and Sulistya, Hanif Ardiansyah and Endraswari, Pepy Dwi and Shirakawa, Toshiro and Hirai, Itaru and Kuntaman, Kuntaman and Koendhori, Eko Budi},
title = {Emerging Coproduction of AmpC Beta-lactamase in Extended-spectrum Beta-lactamase-producing Escherichia coli Clinical Isolates in Indonesia},
journal = {Biomolecular and Health Science Journal},
year = {2024},
volume = {7},
number = {1},
pages = {36--41},
doi = {10.4103/bhsj.bhsj_5_24}
}
EUVIMED